Biofeedback With Heart Sound Following Trauma
Launched by FATMA ÖZCAN · Apr 2, 2025
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, titled "Biofeedback With Heart Sound Following Trauma," is looking at how young people who survived an earthquake cope with stress over time. The study will explore a special type of therapy that uses sound to help measure and improve how their bodies respond to stress. By focusing on the heart and nervous system, researchers hope to better understand how to support these young survivors in managing trauma-related stress.
To be eligible for this study, participants must be university students aged 20 to 25 who experienced the earthquake. The trial is open to both men and women, but they need to be in good health without any serious medical issues, such as infections or heart problems. They should also be non-smokers and not dealing with addiction or any ongoing medical treatments. If you participate, you can expect to engage in some sessions involving sound therapy, which will help researchers learn more about your body’s response to stress after the earthquake.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 30 earthquake survivor university students between 20 and 25 will participate in the experiment. Participants will be healthy, non-obese men (n=15) and women (n=15). In particular, all participants should have experienced the earthquake disaster in the local region. All participants must be free of any chronic or acute infection, neurological, psychiatric, and/or cardiovascular disease.
- Exclusion Criteria:
- • They must be non-smokers, have no alcohol or drug addiction, and not be under any medical treatment. Pregnant or breastfeeding women will not be included in the study.
About Fatma özcan
Fatma Özcan is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With a focus on innovative therapies and treatments, she collaborates with leading researchers and healthcare professionals to design and implement rigorous clinical trials across various therapeutic areas. Her expertise in regulatory compliance and trial management ensures that studies are conducted ethically and efficiently, adhering to the highest standards of scientific integrity. Through her leadership, Fatma Özcan aims to contribute to the development of breakthrough solutions that address unmet medical needs and enhance the quality of care for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Kahramanmaras, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported